A citation-based method for searching scientific literature

Andrew J Thompson, Liwei Cao, Yuanhui Ma, Xiaoning Wang, Jolene K Diedrich, Chika Kikuchi, Shelby Willis, Charli Worth, Ryan McBride, John R Yates, James C Paulson. Cell Host Microbe 2020
Times Cited: 11







List of co-cited articles
64 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exploitation of glycosylation in enveloped virus pathobiology.
Yasunori Watanabe, Thomas A Bowden, Ian A Wilson, Max Crispin. Biochim Biophys Acta Gen Subj 2019
199
45

A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.
Sandhya Bangaru, Shanshan Lang, Michael Schotsaert, Hillary A Vanderven, Xueyong Zhu, Nurgun Kose, Robin Bombardi, Jessica A Finn, Stephen J Kent, Pavlo Gilchuk,[...]. Cell 2019
102
27

A highly conserved neutralizing epitope on group 2 influenza A viruses.
Damian C Ekiert, Robert H E Friesen, Gira Bhabha, Ted Kwaks, Mandy Jongeneelen, Wenli Yu, Carla Ophorst, Freek Cox, Hans J W M Korse, Boerries Brandenburg,[...]. Science 2011
603
27

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.
Hadi M Yassine, Jeffrey C Boyington, Patrick M McTamney, Chih-Jen Wei, Masaru Kanekiyo, Wing-Pui Kong, John R Gallagher, Lingshu Wang, Yi Zhang, M Gordon Joyce,[...]. Nat Med 2015
383
27

Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains.
Hannah L Turner, Jesper Pallesen, Shanshan Lang, Sandhya Bangaru, Sarah Urata, Sheng Li, Christopher A Cottrell, Charles A Bowman, James E Crowe, Ian A Wilson,[...]. PLoS Biol 2019
25
27

Antiviral lectins: Selective inhibitors of viral entry.
Carter A Mitchell, Koreen Ramessar, Barry R O'Keefe. Antiviral Res 2017
73
27

Site-specific glycan analysis of the SARS-CoV-2 spike.
Yasunori Watanabe, Joel D Allen, Daniel Wrapp, Jason S McLellan, Max Crispin. Science 2020
665
27

Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
Barry R O'Keefe, Barbara Giomarelli, Dale L Barnard, Shilpa R Shenoy, Paul K S Chan, James B McMahon, Kenneth E Palmer, Brian W Barnett, David K Meyerholz, Christine L Wohlford-Lenane,[...]. J Virol 2010
190
27

Structure of the Lassa virus glycan shield provides a model for immunological resistance.
Yasunori Watanabe, Jayna Raghwani, Joel D Allen, Gemma E Seabright, Sai Li, Felipe Moser, Juha T Huiskonen, Thomas Strecker, Thomas A Bowden, Max Crispin. Proc Natl Acad Sci U S A 2018
55
27

N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing.
Yanming An, Lisa M Parsons, Ewa Jankowska, Darya Melnyk, Manju Joshi, John F Cipollo. J Virol 2019
31
27

Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions.
Kshitij Khatri, Joshua A Klein, Mitchell R White, Oliver C Grant, Nancy Leymarie, Robert J Woods, Kevan L Hartshorn, Joseph Zaia. Mol Cell Proteomics 2016
65
27

Human lectins and their roles in viral infections.
Christopher P Mason, Alexander W Tarr. Molecules 2015
55
27

Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.
Nicholas C Wu, Jia Xie, Tianqing Zheng, Corwin M Nycholat, Geramie Grande, James C Paulson, Richard A Lerner, Ian A Wilson. Cell Host Microbe 2017
33
18

A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
Nicholas C Wu, Seth J Zost, Andrew J Thompson, David Oyen, Corwin M Nycholat, Ryan McBride, James C Paulson, Scott E Hensley, Ian A Wilson. PLoS Pathog 2017
133
18

Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires.
Kevin R McCarthy, Akiko Watanabe, Masayuki Kuraoka, Khoi T Do, Charles E McGee, Gregory D Sempowski, Thomas B Kepler, Aaron G Schmidt, Garnett Kelsoe, Stephen C Harrison. Immunity 2018
69
18

Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus.
Peter S Lee, Nobuko Ohshima, Robyn L Stanfield, Wenli Yu, Yoshitaka Iba, Yoshinobu Okuno, Yoshikazu Kurosawa, Ian A Wilson. Nat Commun 2014
122
18

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
Mark Throsby, Edward van den Brink, Mandy Jongeneelen, Leo L M Poon, Philippe Alard, Lisette Cornelissen, Arjen Bakker, Freek Cox, Els van Deventer, Yi Guan,[...]. PLoS One 2008
558
18

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.
Davide Corti, Jarrod Voss, Steven J Gamblin, Giosiana Codoni, Annalisa Macagno, David Jarrossay, Sebastien G Vachieri, Debora Pinna, Andrea Minola, Fabrizia Vanzetta,[...]. Science 2011
835
18

Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry.
Esteban Cruz, Joel Cain, Ben Crossett, Veysel Kayser. Hum Vaccin Immunother 2018
18
18

A common solution to group 2 influenza virus neutralization.
Robert H E Friesen, Peter S Lee, Esther J M Stoop, Ryan M B Hoffman, Damian C Ekiert, Gira Bhabha, Wenli Yu, Jarek Juraszek, Wouter Koudstaal, Mandy Jongeneelen,[...]. Proc Natl Acad Sci U S A 2014
132
18




Cross-neutralization of influenza A viruses mediated by a single antibody loop.
Damian C Ekiert, Arun K Kashyap, John Steel, Adam Rubrum, Gira Bhabha, Reza Khayat, Jeong Hyun Lee, Michael A Dillon, Ryann E O'Neil, Aleksandr M Faynboym,[...]. Nature 2012
321
18

Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.
Akiko Watanabe, Kevin R McCarthy, Masayuki Kuraoka, Aaron G Schmidt, Yu Adachi, Taishi Onodera, Keisuke Tonouchi, Timothy M Caradonna, Goran Bajic, Shengli Song,[...]. Cell 2019
83
18

A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin.
Jens C Krause, Tshidi Tsibane, Terrence M Tumpey, Chelsey J Huffman, Christopher F Basler, James E Crowe. J Virol 2011
137
18

Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
Seth J Zost, Juhye Lee, Megan E Gumina, Kaela Parkhouse, Carole Henry, Nicholas C Wu, Chang-Chun D Lee, Ian A Wilson, Patrick C Wilson, Jesse D Bloom,[...]. Cell Rep 2019
9
22

Recent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity.
Wenjie Peng, Robert P de Vries, Oliver C Grant, Andrew J Thompson, Ryan McBride, Buyankhishig Tsogtbaatar, Peter S Lee, Nahid Razi, Ian A Wilson, Robert J Woods,[...]. Cell Host Microbe 2017
100
18

Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape.
Nicholas C Wu, Jakub Otwinowski, Andrew J Thompson, Corwin M Nycholat, Armita Nourmohammad, Ian A Wilson. Nat Commun 2020
17
18

Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit.
Meghan O Altman, Matthew Angel, Ivan Košík, Nídia S Trovão, Seth J Zost, James S Gibbs, Lorenzo Casalino, Rommie E Amaro, Scott E Hensley, Martha I Nelson,[...]. mBio 2019
38
18

A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site.
Nicholas C Wu, Andrew J Thompson, Jia Xie, Chih-Wei Lin, Corwin M Nycholat, Xueyong Zhu, Richard A Lerner, James C Paulson, Ian A Wilson. Nat Commun 2018
31
18

Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.
Yasuhiro Abe, Emi Takashita, Kanetsu Sugawara, Yoko Matsuzaki, Yasushi Muraki, Seiji Hongo. J Virol 2004
161
18

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.
M Gordon Joyce, Adam K Wheatley, Paul V Thomas, Gwo-Yu Chuang, Cinque Soto, Robert T Bailer, Aliaksandr Druz, Ivelin S Georgiev, Rebecca A Gillespie, Masaru Kanekiyo,[...]. Cell 2016
191
18

A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody.
J J Skehel, D J Stevens, R S Daniels, A R Douglas, M Knossow, I A Wilson, D C Wiley. Proc Natl Acad Sci U S A 1984
372
18

Antibody recognition of a highly conserved influenza virus epitope.
Damian C Ekiert, Gira Bhabha, Marc-André Elsliger, Robert H E Friesen, Mandy Jongeneelen, Mark Throsby, Jaap Goudsmit, Ian A Wilson. Science 2009
955
18

Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site.
Eva-Maria Strauch, Steffen M Bernard, David La, Alan J Bohn, Peter S Lee, Caitlin E Anderson, Travis Nieusma, Carly A Holstein, Natalie K Garcia, Kathryn A Hooper,[...]. Nat Biotechnol 2017
72
18

Mapping the antigenic and genetic evolution of influenza virus.
Derek J Smith, Alan S Lapedes, Jan C de Jong, Theo M Bestebroer, Guus F Rimmelzwaan, Albert D M E Osterhaus, Ron A M Fouchier. Science 2004
18

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
Florian Krammer, Ron A M Fouchier, Maryna C Eichelberger, Richard J Webby, Kathryn Shaw-Saliba, Hongquan Wan, Patrick C Wilson, Richard W Compans, Ioanna Skountzou, Arnold S Monto. mBio 2018
116
18

Highly conserved protective epitopes on influenza B viruses.
Cyrille Dreyfus, Nick S Laursen, Ted Kwaks, David Zuijdgeest, Reza Khayat, Damian C Ekiert, Jeong Hyun Lee, Zoltan Metlagel, Miriam V Bujny, Mandy Jongeneelen,[...]. Science 2012
505
18

H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.
Natalie J Thornburg, Heng Zhang, Sandhya Bangaru, Gopal Sapparapu, Nurgun Kose, Rebecca M Lampley, Robin G Bombardi, Yingchun Yu, Stephen Graham, Andre Branchizio,[...]. J Clin Invest 2016
47
18

Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.
Minsun Hong, Peter S Lee, Ryan M B Hoffman, Xueyong Zhu, Jens C Krause, Nick S Laursen, Sung-Il Yoon, Langzhou Song, Lynda Tussey, James E Crowe,[...]. J Virol 2013
101
18


Designed oligomers of cyanovirin-N show enhanced HIV neutralization.
Jennifer R Keeffe, Priyanthi N P Gnanapragasam, Sarah K Gillespie, John Yong, Pamela J Bjorkman, Stephen L Mayo. Proc Natl Acad Sci U S A 2011
25
18

Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2.
Asif Shajahan, Nitin T Supekar, Anne S Gleinich, Parastoo Azadi. Glycobiology 2020
228
18

Potent antiviral activity of carbohydrate-specific algal and leguminous lectins from the Brazilian biodiversity.
Ana C S Gondim, Suzete Roberta da Silva, Leen Mathys, Sam Noppen, Sandra Liekens, Alexandre Holanda Sampaio, Celso S Nagano, Cintia Renata Costa Rocha, Kyria S Nascimento, Benildo S Cavada,[...]. Medchemcomm 2019
11
18


Global aspects of viral glycosylation.
Ieva Bagdonaite, Hans H Wandall. Glycobiology 2018
113
18

Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture.
F J U M van der Meer, C A M de Haan, N M P Schuurman, B J Haijema, W J Peumans, E J M Van Damme, P L Delputte, J Balzarini, H F Egberink. Antiviral Res 2007
30
18

Bitter-sweet symphony: glycan-lectin interactions in virus biology.
Wander Van Breedam, Stefan Pöhlmann, Herman W Favoreel, Raoul J de Groot, Hans J Nauwynck. FEMS Microbiol Rev 2014
83
18

Glycosylation of viral surface proteins probed by mass spectrometry.
Audra A Hargett, Matthew B Renfrow. Curr Opin Virol 2019
19
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.